REFERENCES
- Flamini MI, Fu XD, Sanchez AM, et al. Effects of raloxifene on breast cancer cell migration and invasion through the actin cytoskeleton. J Cell Mol Med 2009;13: 2396–407
- Lambrechts A, Van Troys M, Ampe C. The actin cytoskeleton in normal and pathological cell motility. Int J Biochem Cell Biol 2004;36: 1890–909
- Massaad MJ, Oyoshi MK, Kane J, et al. Binding of WIP to actin is essential for T cell actin cytoskeleton integrity and tissue homing. Mol Cell Biol 2014;34: 4343–54
- Rao J, Li N. Microfilament actin remodeling as a potential target for cancer drug development. Curr Cancer Drug Targets 2004;4: 345–54
- Weygant N, Qu D, May R, et al. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma. Oncotarget 2015;6: 2193–205
- Bailly M. Ena/VASP family: New partners, bigger enigma. Dev Cell 2004;7: 462–3
- Siton O, Bernheim-Groswasser A. Reconstitution of actin-based motility by vasodilator-stimulated phosphoprotein (VASP) depends on the recruitment of F-actin seeds from the solution produced by cofilin. J Biol Chem 2014;289: 31274–86
- Su K, Tian Y, Wang J, et al. HIF-1alpha acts downstream of TNF-alpha to inhibit vasodilator-stimulated phosphoprotein expression and modulates the adhesion and proliferation of breast cancer cells. DNA Cell Biol 2012;31: 1078–87
- Liotta LA, Wewer U, Rao NC, et al. Biochemical mechanisms of tumor invasion and metastasis. Anticancer Drug Des 1987;2: 195–202
- Georgoulis A, Havaki S, Drosos Y, et al. RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures. Ultrastruct Pathol 2012;36: 387–99
- Le Clainche C, Carlier MF. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev 2008;88: 489–513
- Sechi AS, Wehland J. ENA/VASP proteins: Multifunctional regulators of actin cytoskeleton dynamics. Front Biosci 2004;9: 1294–310
- Reinhard M, Jouvenal K, Tripier D, Walter U. Identification, purification, and characterization of a zyxin-related protein that binds the focal adhesion and microfilament protein VASP (vasodilator-stimulated phosphoprotein). Proc Natl Acad Sci USA 1995;92: 7956–60
- Brindle NP, Holt MR, Davies JE, et al. The focal-adhesion vasodilator-stimulated phosphoprotein (VASP) binds to the proline-rich domain in vinculin. Biochem J 1996;318: 753–7
- Yang B, Gao J, Rao Z, et al. Antisense oligonucleotide targeting matrix metalloproteinase-7 (MMP-7) changes the ultrastructure of human A549 lung adenocarcinoma cells. Ultrastruct Pathol 2011;35: 256–9